Table 2 Anatomopathological characteristics for patients with breast cancera
From: Using Resistin, glucose, age and BMI to predict the presence of breast cancer
Tumor grade | Tumor stage | Tumor size | Lymph node involvement | ER, PR, CERB2 |
|---|---|---|---|---|
I- 13 (21.3%) | 0–5 (7.8%) | ≤2 cm- 54 (84.4%) | Yes- 27 (42.2%) | ER+ 53 (82.8%) |
II- 39 (63.9%) | I- 29 (45.3%) | >2 cm- 10 (15.6%) | No- 37 (57.8%) | ER- 5 (7.8%) |
III- 9 (14.8%) | II- 30 (46.9%) | |||
PR+ 52 (81.3%) PR- 6 (9.4%) CERB2+ 18 (28.1%) CERB2–40 (62.5%) |